Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy

BACKGROUND: Inhaled corticosteroids (ICS) are effective maintenance treatments for childhood asthma; however, many children remain uncontrolled. Vilanterol (VI) is an inhaled long-acting beta-2 agonist which, in combination with the ICS fluticasone furoate, is being explored as a once-daily treatmen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Res
Autors principals: Oliver, Amanda J., Covar, Ronina A., Goldfrad, Caroline H., Klein, Ryan M., Pedersen, Søren E., Sorkness, Christine A., Tomkins, Susan A., Villarán, César, Grigg, Jonathan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4820901/
https://ncbi.nlm.nih.gov/pubmed/27044326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0353-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars